Loading clinical trials...
Loading clinical trials...
Phase 3, Single Center, Controlled, Investigator-blinded, Randomized Matched Pair Design Study of CD4 Cell Recovery in HIV-1 Patients With Sustained Virologic Response Comparing Protease Inhibitor and Non-nucleoside Reverse Transcriptase Inhibitor Based Treatment Regimes
Conditions
Interventions
Lopinavir/Ritonavir plus Lamivudine/Zidovudine
Efavirenz plus Lamivudine/Zidovudine
Locations
1
Germany
Medical Clinic I and Department of Pharmacology, University of Cologne
Cologne, Germany
Start Date
January 1, 1999
Primary Completion Date
December 1, 2008
Completion Date
December 1, 2008
Last Updated
September 29, 2009
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT05897099
NCT06665646
Lead Sponsor
University of Cologne
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions